IRLAB Therapeutics (Sweden) Technical Analysis
| IRLAB-A Stock | SEK 1.80 0.01 0.55% |
As of the 2nd of February, IRLAB Therapeutics retains the Risk Adjusted Performance of (0.09), coefficient of variation of (714.54), and Market Risk Adjusted Performance of (24.25). IRLAB Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
IRLAB Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as IRLAB, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IRLABIRLAB |
IRLAB Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IRLAB Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IRLAB Therapeutics.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in IRLAB Therapeutics on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding IRLAB Therapeutics AB or generate 0.0% return on investment in IRLAB Therapeutics over 90 days. IRLAB Therapeutics is related to or competes with Lipum AB, Isofol Medical, Bio Works, Karolinska Development, Initiator Pharma, Annexin Pharmaceuticals, and Xbrane Biopharma. IRLAB Therapeutics AB operates as a drug discovery and development company that provides drugs in the field of neurologi... More
IRLAB Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IRLAB Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IRLAB Therapeutics AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 14.42 | |||
| Value At Risk | (5.12) | |||
| Potential Upside | 4.55 |
IRLAB Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRLAB Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IRLAB Therapeutics' standard deviation. In reality, there are many statistical measures that can use IRLAB Therapeutics historical prices to predict the future IRLAB Therapeutics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (24.26) |
IRLAB Therapeutics February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (24.25) | |||
| Mean Deviation | 2.24 | |||
| Coefficient Of Variation | (714.54) | |||
| Standard Deviation | 3.0 | |||
| Variance | 8.98 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (24.26) | |||
| Maximum Drawdown | 14.42 | |||
| Value At Risk | (5.12) | |||
| Potential Upside | 4.55 | |||
| Skewness | (0.03) | |||
| Kurtosis | 0.9906 |
IRLAB Therapeutics Backtested Returns
IRLAB Therapeutics holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had a -0.15 % return per unit of risk over the last 3 months. IRLAB Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IRLAB Therapeutics' Risk Adjusted Performance of (0.09), market risk adjusted performance of (24.25), and Coefficient Of Variation of (714.54) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.0177, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IRLAB Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding IRLAB Therapeutics is expected to be smaller as well. At this point, IRLAB Therapeutics has a negative expected return of -0.44%. Please make sure to check out IRLAB Therapeutics' treynor ratio, skewness, rate of daily change, as well as the relationship between the value at risk and accumulation distribution , to decide if IRLAB Therapeutics performance from the past will be repeated at future time.
Auto-correlation | 0.14 |
Insignificant predictability
IRLAB Therapeutics AB has insignificant predictability. Overlapping area represents the amount of predictability between IRLAB Therapeutics time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IRLAB Therapeutics price movement. The serial correlation of 0.14 indicates that less than 14.0% of current IRLAB Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | 0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
IRLAB Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
IRLAB Therapeutics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of IRLAB Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About IRLAB Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of IRLAB Therapeutics AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of IRLAB Therapeutics AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on IRLAB Therapeutics price pattern first instead of the macroeconomic environment surrounding IRLAB Therapeutics. By analyzing IRLAB Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of IRLAB Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to IRLAB Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
IRLAB Therapeutics February 2, 2026 Technical Indicators
Most technical analysis of IRLAB help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IRLAB from various momentum indicators to cycle indicators. When you analyze IRLAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (24.25) | |||
| Mean Deviation | 2.24 | |||
| Coefficient Of Variation | (714.54) | |||
| Standard Deviation | 3.0 | |||
| Variance | 8.98 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (24.26) | |||
| Maximum Drawdown | 14.42 | |||
| Value At Risk | (5.12) | |||
| Potential Upside | 4.55 | |||
| Skewness | (0.03) | |||
| Kurtosis | 0.9906 |
IRLAB Therapeutics February 2, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as IRLAB stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1,628 | ||
| Daily Balance Of Power | (0.07) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 1.79 | ||
| Day Typical Price | 1.79 | ||
| Price Action Indicator | 0.01 |
Complementary Tools for IRLAB Stock analysis
When running IRLAB Therapeutics' price analysis, check to measure IRLAB Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRLAB Therapeutics is operating at the current time. Most of IRLAB Therapeutics' value examination focuses on studying past and present price action to predict the probability of IRLAB Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRLAB Therapeutics' price. Additionally, you may evaluate how the addition of IRLAB Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |